COMMUNIQUÉS West-GlobeNewswire

Major shareholder announcement – BlackRock, Inc.

15/05/2024 - 11:45

ANNOUNCEMENT NO. 266 Major shareholder announcement Major shareholder announcement – BlackRock, Inc. Pursuant to Section 30 of the Capital Markets Act, it is hereby announced that BlackRock, Inc. has informed ChemoMetec [...]

Brand New Technology “LPA Synapse” by LQpay Delivers Reliable, Workflow-Integrated Payments for Dental Practices

15/05/2024 - 11:25

FORT LAUDERDALE, Fla., May 15, 2024 (GLOBE NEWSWIRE) -- LQpay , the leading end-to-end patient payments provider, proudly launches LPA Synapse. Building upon the Company’s existing AI and automation technology and [...]

Philips announces exchange ratio for 2023 dividend

15/05/2024 - 11:00

May 15, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), today announced that the exchange ratio for the dividend for the year 2023 is 1 new common share for every 29.2684 existing common shares. [...]

Posting of Annual Report & Notice of AGM - Total Voting Rights

15/05/2024 - 09:58

May 15, 2024 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Posting of Annual Report & Notice of AGM Total Voting Rights Biodexa Pharmaceuticals PLC (NASDAQ: BDRX), a clinical stage biopharmaceutical [...]

VIRBAC: Communiqué précisant les modalités de mise à disposition ou de consultation des documents préparatoires à l’assemblée générale mixte ordinaire et extraordinaire

15/05/2024 - 09:00

Les actionnaires de la société VIRBAC sont avisés qu’une assemblée générale mixte ordinaire et extraordinaire se tiendra le vendredi 21 juin 2024 à 9 heures , dans les bâtiments de VIRBAC direction, 13ème rue L.I.D., [...]

Roche announces FDA approval of one of the first HPV self-collection solutions in the U.S., expanding access and screening options to help eliminate cervical cancer

15/05/2024 - 07:00

More than half of all U.S. cervical cancer patients are underscreened 1 , which makes reducing barriers to sample collection and increasing access to screenings crucial to ultimately helping eliminate this deadly [...]

Vivoryon Therapeutics N.V. to Report Q1 2024 Financial Results and Operational Progress on May 23, 2024

15/05/2024 - 07:00

Vivoryon Therapeutics N.V. to Report Q1 2024 Financial Results and Operational Progress on May 23, 2024 Halle (Saale) / Munich, Germany, May 15, 2024 - Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7 [...]

Pharming Group announces the early redemption of the remaining outstanding €125 million convertible bonds due 2025

15/05/2024 - 07:00

THIS NOTICE IS IMPORTANT AND REQUIRES THE IMMEDIATE ATTENTION OF BONDHOLDERS. IF BONDHOLDERS ARE IN ANY DOUBT AS TO THE ACTION THEY SHOULD TAKE, THEY SHOULD SEEK THEIR OWN FINANCIAL AND LEGAL ADVICE IMMEDIATELY FROM [...]

IHH Spearheads Cancer Care Leadership in Asia With Official Launch of Region’s First Private Proton Therapy Centre

15/05/2024 - 06:38

Mount Elizabeth Novena Hospital (MNH) Singapore is the first private hospital in the region to offer proton therapy; kicked off treatment for first patient on 10 May 2023. Centre has already treated more than 100 [...]

Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Under the Fast Track Status

15/05/2024 - 01:33

TOKYO and CAMBRIDGE, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: [...]

UPDATE - SPR® Therapeutics Announces Publication of Study Providing Evidence of the Impact of SPRINT® PNS Treatment in Relieving Postoperative Knee Pain

15/05/2024 - 00:33

Pain Relief Resulted in Improved Objective Measure of Walking Ability at End of Treatment CLEVELAND, May 14, 2024 (GLOBE NEWSWIRE) -- SPR Therapeutics announced the publication of a multicenter double-blind randomized, [...]

ONWARD® Medical Schedules Webcast to Provide Q1 2024 Business Update

15/05/2024 - 00:21

EINDHOVEN, the Netherlands, May 15, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and [...]

Aeterna Zentaris Reports First Quarter 2024 Financial Results

15/05/2024 - 00:00

Company ended the quarter with $29.5 million in cash DETECT-trial recruitment completed; Company continues to expect the completion of the trial in the second quarter and top-line data in the third quarter of 2024 All- [...]

FibroBiologics Files 2024 First Quarter Report

14/05/2024 - 23:24

HOUSTON, May 14, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 150+ patents issued and pending for the development of therapeutics and [...]

T2 Biosystems Announces CRG’s Conversion from Preferred Stock to Common Stock

14/05/2024 - 23:00

LEXINGTON, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that [...]

UNITY Biotechnology, Inc. Reports First Quarter 2024 Financial Results and Business Updates

14/05/2024 - 23:00

SOUTH SAN FRANCISCO, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today reported [...]

Lowell Farms Inc. Announces Unaudited First Quarter 2024 Financial and Operational Results

14/05/2024 - 23:00

SALINAS, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- Lowell Farms Inc. (the “Company”) (CSE: LOWL; OTCQX: LOWLF), a California cannabis company with advanced distribution and production capabilities including extraction, [...]

Psychemedics Corporation Reports First Quarter 2024 Financial Results

14/05/2024 - 22:55

DALLAS, May 14, 2024 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world’s leading provider of hair testing for drugs of abuse, today announced financial results for the first quarter ended March 31, [...]

Natural Alternatives International, Inc. Announces Fiscal 2024 Q3 and YTD Results

14/05/2024 - 22:30

CARLSBAD, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced [...]